Digital Biomanufacturing Market, By Biologic Type (Antibodies, Vaccines, and Cell & Gene Therapies), By Deployment Type, By Application, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4196
|
Published Date
July 2025
|
Pages
367
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Digital Biomanufacturing Market size was valued at US$ 21,234.65 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
Digital biomanufacturing refers to the integration of advanced digital technologies—such as artificial intelligence (AI), machine learning (ML), data analytics, and automation—into biological production processes. This innovative approach enhances efficiency, precision, and scalability in the manufacturing of biologics, vaccines, and cell and gene therapies. By enabling real-time monitoring, predictive maintenance, and process optimization, digital biomanufacturing significantly improves product quality, reduces operational costs, and accelerates development timelines.
Globally, governments are increasingly recognizing the potential of digital biomanufacturing to revolutionize pharmaceutical production. For example, the U.S. Department of Health and Human Services (HHS) and the European Commission have launched strategic initiatives and funding programs to support the digital transformation of bioproduction. In 2024, the European Union allocated over €1.2 billion under its Horizon Europe program for the development of smart manufacturing in life sciences, including digital bioprocessing. Similarly, in Asia, countries like South Korea and Singapore have introduced national strategies promoting digital biomanufacturing as part of their broader biotech innovation agendas. These government-backed efforts are accelerating global adoption of digital tools in biomanufacturing, ensuring more resilient, responsive, and sustainable pharmaceutical supply chains.
Digital Biomanufacturing Market- Market Dynamics
Surging Demand for Biologics Expected to Propel Market Growth
The rising demand for biologics is significantly accelerating the digital transformation of manufacturing processes. According to the U.S. FDA, biologics accounted for over 45% of new drug approvals in 2023, underscoring their growing importance in the pharmaceutical landscape. This surge is pushing biopharmaceutical companies to adopt digital biomanufacturing technologies to enhance efficiency, ensure consistent product quality, and reduce time-to-market.
Government initiatives promoting smart manufacturing are also driving the integration of digital tools such as AI, machine learning, and automation into bioproduction systems. However, the market faces key challenges, including complex regulatory compliance requirements and the high capital investment needed for implementing digital infrastructure. Despite these barriers, the expansion of AI applications in manufacturing offers strong growth potential. Furthermore, increasing public funding to support innovation, digitalization, and automation in life sciences is helping to create a favorable environment for the adoption of digital biomanufacturing solutions globally.
Digital Biomanufacturing Market- Key Insights
- According to the analysis provided by our research team, the global digital biomanufacturing market is projected to grow at a CAGR of approximately 9.5% during the forecast period 2025–2032.
- Antibodies accounted for the largest market share in 2024 based on Biologic Type segmentation.
- By Deployment Type, on-premises solutions led the market in 2024, driven by enhanced data security and customization needs.
- In terms of Application, biomanufacturing process automation emerged as the dominant segment in 2024, reflecting increased demand for efficiency and precision.
- Process Analytical Technology (PAT) was the leading segment under Technology, owing to its real-time monitoring and control capabilities.
- Among End Users, biopharmaceutical companies held the largest share in 2024, fueled by ongoing investments in digital infrastructure.
- North America remained the top revenue-generating region in 2024, supported by strong R&D activity, a robust regulatory framework, and high biologic production capacity.
Digital Biomanufacturing Market- Segmentation Analysis:
The Global Digital Biomanufacturing Market is segmented on the basis of Biologic Type, Deployment Type, Application, Technology, End User, and Region.
The market for digital biomanufacturing is segmented by biologic type into antibodies, vaccines, cell & gene therapies, and others, with the antibodies segment expected to hold the largest market share during the forecast period. This dominance is largely attributed to the widespread application of monoclonal antibodies in the treatment of chronic conditions such as cancer, rheumatoid arthritis, and other autoimmune disorders. The high production volumes and consistent global demand for therapeutic antibodies continue to drive growth in this segment. Governments worldwide are significantly investing in antibody development, especially post-COVID-19, recognizing their therapeutic potential. For example, the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) and the European Commission’s Horizon Europe program have allocated substantial funding toward monoclonal antibody research and manufacturing capacity expansion. According to the World Health Organization (WHO), the global burden of chronic diseases like cancer and autoimmune disorders continues to rise, further reinforcing the demand for effective biologics like antibodies.
In terms of application, the market is divided into digital bioreactor scaling, remote equipment monitoring, biomanufacturing process automation, and others, with biomanufacturing process automation expected to account for the largest market share. This segment\'s growth is fueled by the increasing need to enhance production efficiency, minimize human error, and streamline complex and sensitive biologics manufacturing workflows. Automation enables greater consistency, faster turnaround times, and improved scalability—key priorities in large-scale biopharmaceutical production. Global governments are actively promoting smart manufacturing practices in the life sciences sector. For instance, the U.S. Food and Drug Administration (FDA) supports the adoption of advanced manufacturing technologies through its Emerging Technology Program, while the European Medicines Agency (EMA) encourages the integration of automation to maintain quality and compliance in biologics manufacturing. These regulatory supports, combined with the growing demand for precision and speed in biomanufacturing, position process automation as a critical driver of growth in the digital biomanufacturing market.
Digital Biomanufacturing Market- Geographical Insights
North America is anticipated to hold the largest share of the global digital biomanufacturing market during the forecast period, driven by its advanced biotechnology infrastructure, strong presence of leading biopharmaceutical companies, and early adoption of artificial intelligence (AI), machine learning, and automation technologies in production processes. Government support plays a critical role, with the U.S. government allocating over $2 billion through its National Biotechnology and Biomanufacturing Initiative (2022–2025) to strengthen domestic biomanufacturing and accelerate innovation.
Meanwhile, the Asia-Pacific region is projected to grow at the fastest rate, supported by expanding biopharmaceutical manufacturing hubs, rising digitalization across healthcare sectors, and strategic public investments. For instance, China\'s 14th Five-Year Plan includes significant funding for smart manufacturing, and India’s Production Linked Incentive (PLI) Scheme offers incentives for pharmaceutical technology upgrades. These developments, coupled with increasing demand for biologics and biosimilars, are accelerating the adoption of digital biomanufacturing technologies across the region.
Digital Biomanufacturing Market- Competitive Landscape:
The growing demand for faster and more precise biologics production is intensifying competition in the digital biomanufacturing market. Companies are increasingly adopting strategies focused on digital integration, automation, and real-time analytics to enhance production efficiency and shorten time-to-market. Investments in smart manufacturing platforms, AI-driven process control, and digital twin technologies are becoming standard approaches to optimize bioprocesses. Additionally, strategic collaborations with technology providers, expansion of cloud-based solutions, and the development of modular bioproduction systems are gaining momentum. These initiatives enable companies to improve operational flexibility, ensure regulatory compliance, and maintain a competitive advantage in a rapidly evolving industry landscape.
Recent Developments:
- In April 2025, Sartorius Stedim Biotech partnered with Tulip Interfaces to launch Biobrain® Operate, a no-code digital suite designed to enhance single-use bioprocessing. This platform integrates seamlessly with Sartorius equipment, accelerating digital transformation efforts in biopharmaceutical manufacturing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIGITAL BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Atos SE
- Danaher Corporation
- Agilent Technologies Inc.
- Donaldson Company, Inc.
- General Electric Company
- Emerson Electric Co.
- Honeywell International Inc.
- Siemens Healthineers AG
- SAP SE
- Bota Biosciences
- e-matica srl
- Culture Biosciences
- Exponential Genomics, Inc.
- OVO Biomanufacturing
- FabricNano
- Symphony Innovation, LLC
- Ample Logic
- Thermo Fisher Scientific
- Bruker
- ABB
- Dassault Systems
- Hamilton Company
- Invert, Inc.
- Eppendorf SE
- Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY BIOLOGIC TYPE- MARKET ANALYSIS, 2019 - 2032
- Antibodies
- Vaccines
- Cell & Gene Therapies
- Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY DEPLOYMENT TYPE- MARKET ANALYSIS, 2019 - 2032
- On-premises
- Cloud-based
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Digital Bioreactor Scaling
- Remote Equipment Monitoring
- Biomanufacturing Process Automation
- Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Process Analytical Technology (PAT)
- Manufacturing Execution System (MES)
- Digital Twins
- Data Analytics Software
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Contract Manufacturing Organizations
- Biopharmaceutical Companies
- Others
GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Digital Biomanufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Digital Biomanufacturing Market Snippet by Biologic Type
2.1.2. Digital Biomanufacturing Market Snippet by Deployment Type
2.1.3. Digital Biomanufacturing Market Snippet by Application
2.1.4. Digital Biomanufacturing Market Snippet by Technology
2.1.5. Digital Biomanufacturing Market Snippet by End User
2.1.6. Digital Biomanufacturing Market Snippet by Country
2.1.7. Digital Biomanufacturing Market Snippet by Region
2.2. Competitive Insights
3. Digital Biomanufacturing Key Market Trends
3.1. Digital Biomanufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Digital Biomanufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Digital Biomanufacturing Market Opportunities
3.4. Digital Biomanufacturing Market Future Trends
4. Digital Biomanufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Digital Biomanufacturing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Digital Biomanufacturing Market Landscape
6.1. Digital Biomanufacturing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Digital Biomanufacturing Market – By Biologic Type
7.1. Overview
7.1.1. Segment Share Analysis, By Biologic Type, 2024 & 2032 (%)
7.1.2. Antibodies
7.1.3. Vaccines
7.1.4. Cell & Gene Therapies
7.1.5. Others
8. Digital Biomanufacturing Market – By Deployment Type
8.1. Overview
8.1.1. Segment Share Analysis, By Deployment Type, 2024 & 2032 (%)
8.1.2. On-premises
8.1.3. Cloud-based
9. Digital Biomanufacturing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Digital Bioreactor Scaling
9.1.3. Remote Equipment Monitoring
9.1.4. Biomanufacturing Process Automation
9.1.5. Others
10. Digital Biomanufacturing Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
10.1.2. Process Analytical Technology (PAT)
10.1.3. Manufacturing Execution System (MES)
10.1.4. Digital Twins
10.1.5. Data Analytics Software
11. Digital Biomanufacturing Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Contract Manufacturing Organizations
11.1.3. Biopharmaceutical Companies
11.1.4. Others
12. Digital Biomanufacturing Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Digital Biomanufacturing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Digital Biomanufacturing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Digital Biomanufacturing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Digital Biomanufacturing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Digital Biomanufacturing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Digital Biomanufacturing Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Atos SE
13.2.2. Danaher Corporation
13.2.3. Agilent Technologies Inc.
13.2.4. Donaldson Company, Inc.
13.2.5. General Electric Company
13.2.6. Emerson Electric Co.
13.2.7. Honeywell International Inc.
13.2.8. Siemens Healthineers AG
13.2.9. SAP SE
13.2.10. Bota Biosciences
13.2.11. e-matica srl
13.2.12. Culture Biosciences
13.2.13. Exponential Genomics, Inc.
13.2.14. OVO Biomanufacturing
13.2.15. FabricNano
13.2.16. Symphony Innovation, LLC
13.2.17. Ample Logic
13.2.18. Thermo Fisher Scientific
13.2.19. Bruker
13.2.20. ABB
13.2.21. Dassault Systems
13.2.22. Hamilton Company
13.2.23. Invert, Inc.
13.2.24. Eppendorf SE
13.2.25. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
